Our Vision and Mission
Our vision for this website is to share and exchange information about deprescribing approaches and deprescribing research with the public, health care providers and researchers.
Our mission is to offer:
- Tools to help patients and providers participate in deprescribing
- Information about ongoing and completed deprescribing initiatives and research projects in Canada
- Links to people around the world who are interested in deprescribing
“Safely reducing or stopping medications is a team effort.”Barbara and Cara
Dr. Barbara Farrell is passionate about deprescribing – especially for the frail elderly. As a pharmacist working in the Bruyère Geriatric Day Hospital, she sees many older people often taking more than 20 medications a day. Working closely with physicians, an interprofessional team and the patients and their families, she is able to help reduce or stop medications safely. More frequently than not, this helps patients feel better, be less confused, fatigued and dizzy. These experiences prompted Dr. Farrell to pursue research in the field of deprescribing and models that improve medication-related care for older people.
Dr. Farrell is currently a scientist with the Bruyère Research Institute and the CT Lamont Primary Health Care Research Centre, an Assistant Professor with the Department of Family Medicine, University of Ottawa, and an Adjunct Assistant Professor with the School of Pharmacy, University of Waterloo. She is also a member of the Ontario Pharmacy Research Collaboration.
In 2011, Dr. Farrell was named the Canadian Pharmacist Association’s “Pharmacist of the Year” for her work in pharmacist education, patient-centred care and research.
Dr. Cara Tannenbaum is a leader in cutting-edge geriatric research both nationally and internationally. As a Professor in the Faculties of Medicine and Pharmacy at the Université de Montréal, she became the inaugural Chair of the Michel Saucier Endowed Fund in Geriatric Pharmacology, Health and Aging of the in 2008, and won the CIHR Betty Haven’s Knowledge Transfer Prize in Aging in 2013 for her work on the EMPOWER study: “Eliminating Medications through Patient Ownership of End Results”. Her EMPOWER brochure for reducing benzodiazepines has since been translated into 10 languages worldwide. As the principal investigator on a CIHR Partnership for Health System Improvement Grant, she founded and co-chairs the Canadian Deprescribing Network, and continues to conduct deprescribing trials involving patients, pharmacists and primary care practitioners across Canada.
In 2015 Dr. Tannenbaum received a Y Woman of Distinction Award for Health, and was appointed Scientific Director of the CIHR Institute of Gender and Health. She is dedicated to her clinical practice as a geriatrician, women’s health specialist and Director of the Geriatric Incontinence Clinic at the Institut universitaire de gériatrie de Montréal, which fuels her vision for her patient-oriented research program.
Dr. Mathieu Boulin
Dr. Vakaramoko Diaby
Dr. Pamela Grassau
Dr. Claude Richard
Dr. Dan Zou
The Bruyère Research Institute provides evidence-based health care and services for the vulnerable and medically complex, with a focus on persons who require sub-acute, geriatric or palliative care. Bruyère is committed to excellence, education, research and innovation, regional partnerships, and bringing care closer to home.
The Ontario Pharmacy Research Collaboration (OPEN) examines the quality, outcomes and value of medication management services provided by pharmacists and other healthcare professionals, with a focus on the needs of diverse populations. Our interdisciplinary research provides knowledge users with evidence for integrating community health care services and improving practice and quality of care for patients.
The Institut universitaire de gériatrie de Montréal (IUGM) is the Quebec leader in clinical practice, specialized care, health promotion and development of knowledge related to aging and seniors’ health.
Its research center is renowned as the largest of its kind throughout French-speaking countries, and brings together activities from contribution of numerous teams from various healthcare sectors.
The Canadian Institutes of Health Research (CIHR) was created in 2000 under the authority of the CIHR Act, and is the Government of Canada’s health research investment agency. CIHR’s mandate is to “excel, according to internationally accepted standards of scientific excellence, in the creation of new knowledge and its translation into improved health for Canadians, more effective health services and products and a strengthened Canadian health care system.
“A recent Canadian study found that almost half of seniors taking five or more medications had an adverse effect that required medical attention.”Family Practice